Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of three successive antiviral treatments on viral heterogeneity in nonresponder chronic hepatitis C patients.

Journal of medical virology - 1 Dec 2001

Thelu M A, Brengel-Pesce K, Leroy V, Attuil V, Drouet E, Seigneurin J M, Zarski J P

Abstract excerpt

The purpose of the present study was to assess the viral diversity of hepatitis C virus (HCV) in six nonresponder patients during three unsuccessful treatments. These patients were treated successively with IFN-alpha2a (IFN-alpha) at a posology of 3.10(6) units (MIU) three times a week, 10 MIU three times a week, and a combination of IFN-alpha (3 MIU) plus ribavirin (1,000 mg/day). However, only two chronically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Viral

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Ribavirin

Share to Viral Proteins

Source

Identifiers

PMID: 11745934
DOI: 10.1002/jmv.2093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of three successive antiviral treatments on viral heterogeneity in nonresponder chronic hepatitis C patients.PMID 11745934Read ↗

Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations.Semantic proximity Read ↗

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcomeSemantic proximity Read ↗

Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.Semantic proximity Read ↗

Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a.Semantic proximity Read ↗

Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy.Semantic proximity Read ↗

HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.Semantic proximity Read ↗

On hepatitis C virus evolution: the interaction between virus and host towards treatment outcome.Semantic proximity Read ↗

Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.Semantic proximity Read ↗

Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing.Semantic proximity Read ↗

Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.